Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas
Stopped Study was terminated at completion of the Phase 1 dose escalation due to loss of financial support.
Conditions
- Advanced Soft Tissue Sarcoma
- Locally Advanced Soft Tissue Sarcoma
- Metastatic Soft Tissue Sarcoma
Interventions
- DRUG: Sirolimus Albumin-bound Nanoparticles
- DRUG: Pazopanib hydrochloride
Sponsor
University of Washington
Collaborators